Literature DB >> 26282431

Interplay among membrane-bound lytic transglycosylase D1, the CreBC two-component regulatory system, the AmpNG-AmpDI-NagZ-AmpR regulatory circuit, and L1/L2 β-lactamase expression in Stenotrophomonas maltophilia.

Yi-Wei Huang1, Chao-Jung Wu1, Rouh-Mei Hu2, Yi-Tsung Lin3, Tsuey-Ching Yang4.   

Abstract

Lytic transglycosylases (LTs) are an important class of enzymes involved in peptidoglycan (PG) cleavage, with the concomitant formation of an intramolecular 1,6-anhydromuramoyl reaction product. There are six annotated LT genes in the Stenotrophomonas maltophilia genome, including genes for five membrane-bound LTs (mltA, mltB1, mltB2, mltD1, and mltD2) and a gene for soluble LT (slt). Six LTs of S. maltophilia KJ were systematically mutated, yielding the ΔmltA, ΔmltB1, ΔmltB2, ΔmltD1, ΔmltD2, and Δslt mutants. Inactivation of mltD1 conferred a phenotype of elevated uninduced β-lactamase activity. The underlying mechanism responsible for this phenotype was elucidated by the construction of several mutants and determination of β-lactamase activity. The expression of the genes assayed was assessed by quantitative reverse transcriptase PCR and a promoter transcription fusion assay. The results demonstrate that ΔmltD1 mutant-mediated L1/L2 β-lactamase expression involved the creBC two-component regulatory system (TCS) and the ampNG-ampDI-nagZ-ampR regulatory circuit. The inactivation of mltD1 resulted in mltB1 and mltD2 upexpression in a creBC- and ampNG-dependent manner. The overexpressed MltB1 and MltD2 activity contributed to the expression of the L1/L2 β-lactamase genes via the ampNG-ampDI-nagZ-ampR regulatory circuit. These findings reveal, for the first time, a linkage between LTs, the CreBC TCS, the ampNG-ampDI-nagZ-ampR regulatory circuit, and L1/L2 β-lactamase expression in S. maltophilia.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282431      PMCID: PMC4604389          DOI: 10.1128/AAC.05179-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  Lytic transglycosylases: bacterial space-making autolysins.

Authors:  Edie Scheurwater; Chris W Reid; Anthony J Clarke
Journal:  Int J Biochem Cell Biol       Date:  2007-03-30       Impact factor: 5.085

2.  Induction of beta-lactamase production in Aeromonas hydrophila is responsive to beta-lactam-mediated changes in peptidoglycan composition.

Authors:  Amy E Tayler; Juan A Ayala; Pannika Niumsup; Katrin Westphal; Jenny A Baker; Lufei Zhang; Timothy R Walsh; Bernd Wiedemann; Peter M Bennett; Matthew B Avison
Journal:  Microbiology       Date:  2010-04-29       Impact factor: 2.777

3.  AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia.

Authors:  Yi-Wei Huang; Cheng-Wen Lin; Rouh-Mei Hu; Yu-Tzu Lin; Tung-Ching Chung; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Inactivation of mrcA gene derepresses the basal-level expression of L1 and L2 β-lactamases in Stenotrophomonas maltophilia.

Authors:  Cheng-Wen Lin; Hsin-Chieh Lin; Yi-Wei Huang; Tung-Ching Chung; Tsuey-Ching Yang
Journal:  J Antimicrob Chemother       Date:  2011-06-30       Impact factor: 5.790

Review 5.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  The role of AmpR in regulation of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia.

Authors:  Cheng-Wen Lin; Yi-Wei Huang; Rouh-Mei Hu; Kai-Hung Chiang; Tsuey-Ching Yang
Journal:  Res Microbiol       Date:  2008-11-28       Impact factor: 3.992

7.  Defining the growth conditions and promoter-proximal DNA sequences required for activation of gene expression by CreBC in Escherichia coli.

Authors:  S James L Cariss; Amy E Tayler; Matthew B Avison
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

8.  AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.

Authors:  Tsuey-Ching Yang; Yi-Wei Huang; Rouh-Mei Hu; Shao-Cheng Huang; Yu-Tzu Lin
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

9.  Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.

Authors:  Bartolomé Moya; Andreas Dötsch; Carlos Juan; Jesús Blázquez; Laura Zamorano; Susanne Haussler; Antonio Oliver
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

10.  The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.

Authors:  Lisa C Crossman; Virginia C Gould; J Maxwell Dow; Georgios S Vernikos; Aki Okazaki; Mohammed Sebaihia; David Saunders; Claire Arrowsmith; Tim Carver; Nicholas Peters; Ellen Adlem; Arnaud Kerhornou; Angela Lord; Lee Murphy; Katharine Seeger; Robert Squares; Simon Rutter; Michael A Quail; Mari-Adele Rajandream; David Harris; Carol Churcher; Stephen D Bentley; Julian Parkhill; Nicholas R Thomson; Matthew B Avison
Journal:  Genome Biol       Date:  2008-04-17       Impact factor: 13.583

View more
  12 in total

1.  Disruption of mpl Activates β-Lactamase Production in Stenotrophomonas maltophilia and Pseudomonas aeruginosa Clinical Isolates.

Authors:  Karina Calvopiña; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 2.  Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance.

Authors:  David A Dik; Jed F Fisher; Shahriar Mobashery
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

3.  Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.

Authors:  Maria F Mojica; Krisztina M Papp-Wallace; Magdalena A Taracila; Melissa D Barnes; Joseph D Rutter; Michael R Jacobs; John J LiPuma; Thomas J Walsh; Alejandro J Vila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 4.  Lytic transglycosylases: concinnity in concision of the bacterial cell wall.

Authors:  David A Dik; Daniel R Marous; Jed F Fisher; Shahriar Mobashery
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-23       Impact factor: 8.250

Review 5.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

6.  Inactivation of Lytic Transglycosylases Increases Susceptibility to Aminoglycosides and Macrolides by Altering the Outer Membrane Permeability of Stenotrophomonas maltophilia.

Authors:  Chao-Jung Wu; Yi-Wei Huang; Yi-Tsung Lin; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

7.  Expression and Functions of CreD, an Inner Membrane Protein in Stenotrophomonas maltophilia.

Authors:  Hsin-Hui Huang; Yi-Tsung Lin; Wei-Ching Chen; Yi-Wei Huang; Shiang-Jiuun Chen; Tsuey-Ching Yang
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

8.  Deletion of Lytic Transglycosylases Increases Beta-Lactam Resistance in Shewanella oneidensis.

Authors:  Jianhua Yin; Yiyang Sun; Yijuan Sun; Zhiliang Yu; Juanping Qiu; Haichun Gao
Journal:  Front Microbiol       Date:  2018-01-22       Impact factor: 5.640

9.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

10.  Impacts of Penicillin Binding Protein 2 Inactivation on β-Lactamase Expression and Muropeptide Profile in Stenotrophomonas maltophilia.

Authors:  Yi-Wei Huang; Yu Wang; Yun Lin; Chin Lin; Yi-Tsung Lin; Cheng-Chih Hsu; Tsuey-Ching Yang
Journal:  mSystems       Date:  2017-08-29       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.